Search
Showing results for "Professor"
Research
Toll-like receptor 2 ligands inhibit Th2 responses to mite allergenThere is intense interest in the interaction between microbial compounds and allergy.
Research
Immunogenicity and boosting following a reduced number of doses of a Pneumococcal Conjugate Vaccine in infants and toddlersThe minimum number of doses of pneumococcal conjugate vaccine required for protection is not known. We studied the immunogenicity of a reduced schedule in...
News & Events
Major donation to change the landscape of rare and undiagnosed diseaseThe Kids Research Institute Australia is proud to be a part of the Rare Care Comprehensive Centre (RCCC) for children with rare and undiagnosed disease, made possible thanks to one of Western Australia’s biggest philanthropic gifts.
News & Events
Improving health access for children and families living with intellectual disabilityA project led by The Kids Research Institute Australia’s child disability team will seek to reduce potentially preventable hospitalisations and build health literacy for children and young people with intellectual disability.
News & Events
The impact on pregnant womenProfessor Silva says pregnant women are also more vulnerable to the heat.
News & Events
Infectious Disease & Vaccination Public SeminarHear the facts about vaccination and infectious disease from some of Australia's leading experts: Professor Jonathan Carapetis, Dr Peter Richmond
News & Events
Perth researchers test stress link to asthmaScientists at The Kids for Child Health Research have launched an innovative project to test the relationship between stress and asthma.
Research
Predicting long term lung health outcomes in young adults born very preterm (WALHIP 19 year old follow-up)This study will conduct a detailed lung health assessment in a follow-up of a group of preterm individuals at 19 years of age.
Research
Preterm Paediatric Inhaled Corticosteroids Intervention (PICSI)Understanding if ongoing inflammation in the lungs contributes to the poor lung health experienced by some children who were born preterm.
START Phage WA was formed to pave the way towards treating AMR infections with phage therapy in Western Australia.